Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 2167 record(s)

Req # A-2021-001082

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 21-106962-511, Possible Priorities for the Deputy Minister Community of Science and Technology.

Organization: Health Canada

6 page(s)
February 2024

Req # A-2022-000779

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-075262-896, Follow Up to 2019 National Indigenous Economic Development Board Progress Report Recommendations.

Organization: Health Canada

210 page(s)
February 2024

Req # A-2023-001092

Adverse Drug Reactions (ADRs). Report numbers: E2B_06622636, E2B_06621695.

Organization: Health Canada

56 page(s)
February 2024

Req # A-2023-001173

Adverse Drug Reaction (ADR). Report number: E2B_02997619.

Organization: Health Canada

34 page(s)
February 2024

Req # A-2021-001996

Briefing notes and attachments regarding the January 17, 2022 authorization of PAXLOVID TM for patients with mild to moderate COVID-19 at high risk of developing serious disease from November 1, 2021 to February 1, 2022.

Organization: Health Canada

12 page(s)
February 2024

Req # A-2022-001027

The number of prescription requests for psychedelic drugs that were made and the number of prescriptions that were authorized by Health Canada since January 5, 2022.

Organization: Health Canada

4 page(s)
February 2024

Req # A-2023-000268

Module 5.2 (Tabular Listing of all Clinical Studies) for pms-Iron Sucrose that received a Notice of Compliance on 30 July 2020. Drug Identification Number (DIN) 02502917.

Organization: Health Canada

2 page(s)
February 2024

Req # A-2023-000395

The clinical trails for the premarket approval of the Selective Serotonin Reuptake Inhibitors (SNRI) antidepressant Effexor. The table of contents for all of those 12 paper volumes.

Organization: Health Canada

307 page(s)
February 2024

Req # A-2023-000716

All records pertaining to the medical relocations of Canadians facilitated or financed by the federal government from 2018 to August 20, 2024.

Organization: Health Canada

1 page(s)
February 2024

Req # A-2023-001153

A report/speadsheet showing the total number of consultant hired and all corresponding costs, broken down by department/agency and calendar year (2015 - 2023).

Organization: Health Canada

3 page(s)
February 2024
Date modified: